Kadowaki T, Chin R, Ozeki A, Imaoka T, Ogawa Y (2022) Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial
If you have been diagnosed with diabetic retinopathy, follow your eye physicians recommendations on how closely you should be monitored
Quick Answer: Semaglutide injected into muscle tissue may cause increased pain and altered absorption, though this route was not studied in clinical trials and is not FDA-approved
A researcher who normally injects at 8am Eastern time flies to the West Coast and injects at 8am Pacific, which is actually 11am Eastern
One small crossover trial found that morning semaglutide injections before 8am produced roughly 15% lower post-prandial glucose compared to evening doses after 8pm